Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment

Vasilios Kotsis, Jens Jordan, Dragan Micic, Nicholas Finer, Deborah R. Leitner, Hermann Toplak, Lale Tokgozoglu, Vasilios Athyros, Moses Elisaf, Theodosios D. Filippatos, Josep Redon, Pau Redon, Christina Antza, Konstantinos Tsioufis, Guido Grassi, Gino Seravalle, Antonio Coca, Cristina Sierra, Empar Lurbe, Stella StabouliBojan Jelakovic, Peter M. Nilsson

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Obesity is a key factor for cardiovascular diseases and complications. Obesity is associated with hypertension, dyslipidemia and type II diabetes, which are the major predictors of cardiovascular disease in the future. It predisposes for atrial fibrillation, heart failure, sudden cardiac death, renal disease and ischemic stroke that are the main causes of cardiovascular hospitalization and mortality. As obesity and the cardiovascular effects on the vessels and the heart start early in life, even from childhood, it is important for health policies to prevent obesity very early before the disease manifestation emerge. Key roles in the prevention are strategies to increase physical exercise, reduce body weight and to prevent or treat hypertension, lipids disorders and diabetes earlier and efficiently to prevent cardiovascular complications. Epidemiology and mechanisms of obesity-induced hypertension, diabetes and dyslipidemia will be reviewed and the role of lifestyle modification and treatment strategies in obesity will be updated and analyzed. The best treatment options for people with obesity, hypertension, diabetes and dyslipidemia will discussed.

Original languageEnglish
Pages (from-to)1427-1440
Number of pages14
JournalJournal of Hypertension
Volume36
Issue number7
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

Dyslipidemias
Practice Guidelines
Obesity
Hypertension
Therapeutics
Cardiovascular Diseases
Sudden Cardiac Death
Health Policy
Atrial Fibrillation
Type 2 Diabetes Mellitus
Life Style
Epidemiology
Hospitalization
Heart Failure
Stroke
Body Weight
Exercise
Kidney
Lipids
Mortality

Keywords

  • cardiovascular risk
  • diabetes
  • dyslipidemia
  • guidelines
  • hypertension
  • obesity

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Obesity and cardiovascular risk : A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment. / Kotsis, Vasilios; Jordan, Jens; Micic, Dragan; Finer, Nicholas; Leitner, Deborah R.; Toplak, Hermann; Tokgozoglu, Lale; Athyros, Vasilios; Elisaf, Moses; Filippatos, Theodosios D.; Redon, Josep; Redon, Pau; Antza, Christina; Tsioufis, Konstantinos; Grassi, Guido; Seravalle, Gino; Coca, Antonio; Sierra, Cristina; Lurbe, Empar; Stabouli, Stella; Jelakovic, Bojan; Nilsson, Peter M.

In: Journal of Hypertension, Vol. 36, No. 7, 01.07.2018, p. 1427-1440.

Research output: Contribution to journalReview article

Kotsis, V, Jordan, J, Micic, D, Finer, N, Leitner, DR, Toplak, H, Tokgozoglu, L, Athyros, V, Elisaf, M, Filippatos, TD, Redon, J, Redon, P, Antza, C, Tsioufis, K, Grassi, G, Seravalle, G, Coca, A, Sierra, C, Lurbe, E, Stabouli, S, Jelakovic, B & Nilsson, PM 2018, 'Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment', Journal of Hypertension, vol. 36, no. 7, pp. 1427-1440. https://doi.org/10.1097/HJH.0000000000001730
Kotsis, Vasilios ; Jordan, Jens ; Micic, Dragan ; Finer, Nicholas ; Leitner, Deborah R. ; Toplak, Hermann ; Tokgozoglu, Lale ; Athyros, Vasilios ; Elisaf, Moses ; Filippatos, Theodosios D. ; Redon, Josep ; Redon, Pau ; Antza, Christina ; Tsioufis, Konstantinos ; Grassi, Guido ; Seravalle, Gino ; Coca, Antonio ; Sierra, Cristina ; Lurbe, Empar ; Stabouli, Stella ; Jelakovic, Bojan ; Nilsson, Peter M. / Obesity and cardiovascular risk : A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment. In: Journal of Hypertension. 2018 ; Vol. 36, No. 7. pp. 1427-1440.
@article{e879c15f944940e7b53eb84971af65fe,
title = "Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment",
abstract = "Obesity is a key factor for cardiovascular diseases and complications. Obesity is associated with hypertension, dyslipidemia and type II diabetes, which are the major predictors of cardiovascular disease in the future. It predisposes for atrial fibrillation, heart failure, sudden cardiac death, renal disease and ischemic stroke that are the main causes of cardiovascular hospitalization and mortality. As obesity and the cardiovascular effects on the vessels and the heart start early in life, even from childhood, it is important for health policies to prevent obesity very early before the disease manifestation emerge. Key roles in the prevention are strategies to increase physical exercise, reduce body weight and to prevent or treat hypertension, lipids disorders and diabetes earlier and efficiently to prevent cardiovascular complications. Epidemiology and mechanisms of obesity-induced hypertension, diabetes and dyslipidemia will be reviewed and the role of lifestyle modification and treatment strategies in obesity will be updated and analyzed. The best treatment options for people with obesity, hypertension, diabetes and dyslipidemia will discussed.",
keywords = "cardiovascular risk, diabetes, dyslipidemia, guidelines, hypertension, obesity",
author = "Vasilios Kotsis and Jens Jordan and Dragan Micic and Nicholas Finer and Leitner, {Deborah R.} and Hermann Toplak and Lale Tokgozoglu and Vasilios Athyros and Moses Elisaf and Filippatos, {Theodosios D.} and Josep Redon and Pau Redon and Christina Antza and Konstantinos Tsioufis and Guido Grassi and Gino Seravalle and Antonio Coca and Cristina Sierra and Empar Lurbe and Stella Stabouli and Bojan Jelakovic and Nilsson, {Peter M.}",
year = "2018",
month = "7",
day = "1",
doi = "10.1097/HJH.0000000000001730",
language = "English",
volume = "36",
pages = "1427--1440",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Obesity and cardiovascular risk

T2 - A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment

AU - Kotsis, Vasilios

AU - Jordan, Jens

AU - Micic, Dragan

AU - Finer, Nicholas

AU - Leitner, Deborah R.

AU - Toplak, Hermann

AU - Tokgozoglu, Lale

AU - Athyros, Vasilios

AU - Elisaf, Moses

AU - Filippatos, Theodosios D.

AU - Redon, Josep

AU - Redon, Pau

AU - Antza, Christina

AU - Tsioufis, Konstantinos

AU - Grassi, Guido

AU - Seravalle, Gino

AU - Coca, Antonio

AU - Sierra, Cristina

AU - Lurbe, Empar

AU - Stabouli, Stella

AU - Jelakovic, Bojan

AU - Nilsson, Peter M.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Obesity is a key factor for cardiovascular diseases and complications. Obesity is associated with hypertension, dyslipidemia and type II diabetes, which are the major predictors of cardiovascular disease in the future. It predisposes for atrial fibrillation, heart failure, sudden cardiac death, renal disease and ischemic stroke that are the main causes of cardiovascular hospitalization and mortality. As obesity and the cardiovascular effects on the vessels and the heart start early in life, even from childhood, it is important for health policies to prevent obesity very early before the disease manifestation emerge. Key roles in the prevention are strategies to increase physical exercise, reduce body weight and to prevent or treat hypertension, lipids disorders and diabetes earlier and efficiently to prevent cardiovascular complications. Epidemiology and mechanisms of obesity-induced hypertension, diabetes and dyslipidemia will be reviewed and the role of lifestyle modification and treatment strategies in obesity will be updated and analyzed. The best treatment options for people with obesity, hypertension, diabetes and dyslipidemia will discussed.

AB - Obesity is a key factor for cardiovascular diseases and complications. Obesity is associated with hypertension, dyslipidemia and type II diabetes, which are the major predictors of cardiovascular disease in the future. It predisposes for atrial fibrillation, heart failure, sudden cardiac death, renal disease and ischemic stroke that are the main causes of cardiovascular hospitalization and mortality. As obesity and the cardiovascular effects on the vessels and the heart start early in life, even from childhood, it is important for health policies to prevent obesity very early before the disease manifestation emerge. Key roles in the prevention are strategies to increase physical exercise, reduce body weight and to prevent or treat hypertension, lipids disorders and diabetes earlier and efficiently to prevent cardiovascular complications. Epidemiology and mechanisms of obesity-induced hypertension, diabetes and dyslipidemia will be reviewed and the role of lifestyle modification and treatment strategies in obesity will be updated and analyzed. The best treatment options for people with obesity, hypertension, diabetes and dyslipidemia will discussed.

KW - cardiovascular risk

KW - diabetes

KW - dyslipidemia

KW - guidelines

KW - hypertension

KW - obesity

UR - http://www.scopus.com/inward/record.url?scp=85048343809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048343809&partnerID=8YFLogxK

U2 - 10.1097/HJH.0000000000001730

DO - 10.1097/HJH.0000000000001730

M3 - Review article

AN - SCOPUS:85048343809

VL - 36

SP - 1427

EP - 1440

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 7

ER -